Truist Financial’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-29,859
Closed -$389K 2571
2020
Q3
$389K Sell
29,859
-2,274
-7% -$29.6K ﹤0.01% 1834
2020
Q2
$365K Sell
32,133
-2,429
-7% -$27.6K ﹤0.01% 1797
2020
Q1
$494K Sell
34,562
-2,580
-7% -$36.9K ﹤0.01% 1546
2019
Q4
$1.01M Buy
37,142
+2,559
+7% +$69.7K ﹤0.01% 1414
2019
Q3
$990K Sell
34,583
-3,174
-8% -$90.9K 0.02% 450
2019
Q2
$1.05M Sell
37,757
-8,748
-19% -$243K 0.02% 446
2019
Q1
$1.54M Sell
46,505
-3,729
-7% -$124K 0.03% 396
2018
Q4
$1.46M Sell
50,234
-7,438
-13% -$216K 0.03% 391
2018
Q3
$2.65M Sell
57,672
-12,955
-18% -$596K 0.05% 322
2018
Q2
$2.64M Sell
70,627
-20,769
-23% -$776K 0.05% 323
2018
Q1
$2.7M Sell
91,396
-26,941
-23% -$796K 0.05% 318
2017
Q4
$4.06M Sell
118,337
-31,808
-21% -$1.09M 0.08% 270
2017
Q3
$5.43M Sell
150,145
-61,260
-29% -$2.22M 0.11% 234
2017
Q2
$5.46M Buy
211,405
+9,174
+5% +$237K 0.11% 227
2017
Q1
$3.88M Buy
202,231
+21,058
+12% +$404K 0.08% 277
2016
Q4
$3.02M Buy
181,173
+26,737
+17% +$446K 0.06% 306
2016
Q3
$3.18M Buy
154,436
+23,139
+18% +$476K 0.07% 308
2016
Q2
$4.02M Buy
131,297
+4,853
+4% +$149K 0.08% 265
2016
Q1
$4.73M Sell
126,444
-3,288
-3% -$123K 0.12% 197
2015
Q4
$5.6M Sell
129,732
-446
-0.3% -$19.2K 0.15% 171
2015
Q3
$4.88M Sell
130,178
-7,011
-5% -$263K 0.13% 194
2015
Q2
$4.66M Buy
137,189
+4,997
+4% +$170K 0.13% 195
2015
Q1
$4.68M Buy
132,192
+1,959
+2% +$69.4K 0.13% 184
2014
Q4
$4.44M Sell
130,233
-4,087
-3% -$139K 0.13% 185
2014
Q3
$5.18M Sell
134,320
-8,748
-6% -$337K 0.16% 160
2014
Q2
$5.57M Sell
143,068
-3,629
-2% -$141K 0.17% 148
2014
Q1
$5.02M Sell
146,697
-972
-0.7% -$33.2K 0.16% 161
2013
Q4
$3.1M Buy
147,669
+6,950
+5% +$146K 0.1% 220
2013
Q3
$3.31M Buy
140,719
+23,942
+21% +$562K 0.12% 203
2013
Q2
$3.14M Buy
+116,777
New +$3.14M 0.12% 209